The U.S. Food and Drug Administration approved 2025-26 COVID-19 vaccines for anyone age 65 and older and any person 6 months and older who has at least one underlying health condition that increases ...
Covid-19 levels have been rising in the United States again. Emergency department visits associated with Covid-19 have been trending up for weeks, according to the US Centers for Disease Control and ...
Emergent BioSolutions Inc (NYSE:EBS), through its subsidiary Emergent Manufacturing Operations Baltimore, has reached a settlement with Janssen Pharmaceuticals, Inc., a branch of Johnson & Johnson ...
Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...
The XFG variant of the severe acute respiratory syndrome coronavirus 2 as continued to spread as the U.S. heads into peak Summer travel season. (Photo by I RYU/VCG via Getty Images) There’s another ...
After the U.S. Food and Drug Administration (FDA) approved the emergency use of the 2024-2025 COVID-19 vaccines many questions are beginning to circulate. In the FDA's press release on Aug. 22, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results